YJYu-Jin Jeong

Yu-Jin Jeong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yu-Jin Jeong has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Moo-Seung Lee

    Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea

    4 shared publications
  • Kyung-Soo Lee

    Environmental Diseases Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-Gu, Daejeon 34141, Republic of Korea

    2 shared publications
  • Mirim Kim

    Environmental Diseases Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-Gu, Daejeon 34141, Republic of Korea

    2 shared publications
  • Chang-Ung Kim

    College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea

    1 shared publication
  • Jun Young Park

    Environmental Diseases Research Center, Korea Research Institute of Bioscience and Biotechnology, 125 Gwahak-ro, Yuseong-Gu, Daejeon 34141, Republic of Korea

    1 shared publication
  • Jun-Young Park

    Environmental Diseases Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea

    1 shared publication

Latest Publications

  • Open Access

    Shiga Toxin Induces Apoptosis via ROS–Caspase Activation in Human Cerebral Endothelial Cell Line hCMEC/D3 and Astrocyte Co-Culture

    by Mirim Kim, Kyung-Soo Lee, Jun Young Park, Chang-Ung Kim, Yu-Jin Jeong, Moo-Seung Lee

    Mirim Kim, Kyung-Soo Lee, Jun Young Park, Chang-Ung Kim, Yu-Jin Jeong, and Moo-Seung Lee. J. Microbiol. Biotechnol. 2026;36:1-13. https://doi.org/10.4014/jmb.2512.12006

  • Open Access

    Advanced Three-Dimensional Cell Culture Models for Investigating Enterohaemorrhagic Escherichia coli Pathogenesis and Shiga Toxin-Mediated Injury

    by So-Hyeon Park, Mirim Kim, Yu-Jin Jeong, Moo-Seung Lee

    So-Hyeon Park, Mirim Kim, Yu-Jin Jeong, and Moo-Seung Lee. J. Microbiol. Biotechnol. 2025;35:1-8. https://doi.org/10.4014/jmb.2507.07021


  • The Fatal Role of Enterohaemorrhagic Escherichia coli Shiga Toxin-associated Extracellular Vesicles in Host Cells

    by Kyung-Soo Lee, Jun-Young Park, Yu-Jin Jeong, Moo-Seung Lee

    Enterohemorrhagic Escherichia coli (EHEC) is a specific subset of Shiga toxin-producing Escherichia coli (STEC) strains that are characterized by their ability to cause bloody diarrhea (hemorrhagic colitis) and potentially life-threatening, extraintestinal complications such as hemolytic uremic syndrome (HUS), which is associated with acute renal failure., contributing to severe clinical outcomes. The Shiga toxins (Stxs), produced by EHEC, are primary virulence factors. These potent cytotoxins are composed of one enzymatically active A subunit (StxA) and five receptor-binding B subunits (StxB). Although the toxins are primarily associated with cytotoxic effects, they also elicit other pathogenic consequences due to their induction of a number of biological processes, including apoptosis through ER-stress, pro-inflammatory responses, autophagy, and post-translational modification (PTM). Moreover, several studies have reported the association between Stxs and extracellular vesicles (EVs), including microvesicles and exosomes, demonstrating that Stx-containing EVs secreted by intoxicated macrophages are taken up by recipient cells, such as toxin-sensitive renal proximal tubular epithelial cells. This mechanism likely contributes to the spreading of Stxs within the host, and may exacerbate gastrointestinal illnesses and kidney dysfunction. In this review, we summarize recent findings relating to the host responses, in different types of cells in vitro and in animal models, mediated by Stxs-containing exosomes. Due to their unique properties, EVs have been explored as therapeutic agents, drug delivery systems, and diagnostic tools. Thus, potential therapeutic applications of EVs in EHEC Stxs-mediated pathogenesis are also briefly reviewed.


  • Open Access

    Escherichia coli Shiga Toxins and Gut Microbiota Interactions

    by Kyung-Soo Lee, Yu-Jin Jeong, Moo-Seung Lee

    Escherichia coli (EHEC) and Shigella dysenteriae serotype 1 are enterohemorrhagic bacteria that induce hemorrhagic colitis. This, in turn, may result in potentially lethal complications, such as hemolytic uremic syndrome (HUS), which is characterized by thrombocytopenia, acute renal failure, and neurological abnormalities. Both species of bacteria produce Shiga toxins (Stxs), a phage-encoded exotoxin inhibiting protein synthesis in host cells that are primarily responsible for bacterial virulence. Although most studies have focused on the pathogenic roles of Stxs as harmful substances capable of inducing cell death and as proinflammatory factors that sensitize the host target organs to damage, less is known about the interface between the commensalism of bacterial communities and the pathogenicity of the toxins. The gut contains more species of bacteria than any other organ, providing pathogenic bacteria that colonize the gut with a greater number of opportunities to encounter other bacterial species. Notably, the presence in the intestines of pathogenic EHEC producing Stxs associated with severe illness may have compounding effects on the diversity of the indigenous bacteria and bacterial communities in the gut. The present review focuses on studies describing the roles of Stxs in the complex interactions between pathogenic Shiga toxin-producing E. coli, the resident microbiome, and host tissues. The determination of these interactions may provide insights into the unresolved issues regarding these pathogens.